Anty-VEGF therapy in the treatment of myopic macular 
choroidal neovascularization – cases report

Małgorzata Figurska; Andrzej Stankiewicz

Full text

4/2008 vol. 110

Case report

Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization – cases report

Małgorzata Figurska ¹

,

Andrzej Stankiewicz ¹

Z Kliniki Okulistyki Wojskowego Instytutu Medycznego w Warszawie

Data publikacji online: 2008/12/20

Article file

70_004_2008_KAZ_FIGURSKA_TERAPIA_ANTY.pdf

AMA

Figurska M, Stankiewicz A. Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization – cases report. Klinika Oczna / Acta Ophthalmologica Polonica. 2008;110(4):387-391.

APA

Figurska, M., & Stankiewicz, A. (2008). Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization – cases report. Klinika Oczna / Acta Ophthalmologica Polonica, 110(4), 387-391.

Chicago

Figurska, Małgorzata, and Andrzej Stankiewicz. 2008. "Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization – cases report". Klinika Oczna / Acta Ophthalmologica Polonica 110 (4): 387-391.

Harvard

Figurska, M., and Stankiewicz, A. (2008). Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization – cases report. Klinika Oczna / Acta Ophthalmologica Polonica, 110(4), pp.387-391.

MLA

Figurska, Małgorzata et al. "Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization – cases report." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 110, no. 4, 2008, pp. 387-391.

Vancouver

Figurska M, Stankiewicz A. Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization – cases report. Klinika Oczna / Acta Ophthalmologica Polonica. 2008;110(4):387-391.

SUBMIT YOUR PAPER

Share

Integrated with

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications